CALISTOGA PHARMACEUTICALS
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases. The PI3K pathway is a critical cellular pathway involved in cell survival and immune cell activation. Calistoga Pharmaceuticals' small-molecule therapeutic candidates inhibit specific isoforms of the PI3K pathway, providing a targeted treatment approach designed to maximize clinical... outcome and limit unwanted side effects. Calistoga Pharmaceuticals' lead product, CAL-101, an oral delta-isoform selective PI3K inhibitor, has demonstrated promising clinical responses in patients with B-cell malignancies and is currently being evaluated in multiple clinical trials. In addition to CAL-101, Calistoga Pharmaceuticals' product development pipeline includes other selective PI3K inhibitors in early preclinical development or ready for initial clinical trials in patients with cancer or inflammatory diseases.
CALISTOGA PHARMACEUTICALS
Industry:
Alternative Medicine Biotechnology Medical
Founded:
2006-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.calistogapharma.com
Total Employee:
1+
Status:
Active
Contact:
07804443213
Total Funding:
97.2 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Amazon Amazon Virginia Region NameBright Citrix NetScaler StatCounter
Similar Organizations
Epicyte Pharmaceuticals
Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.
KinDex Pharmaceuticals
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Current Employees Featured
Founder
Investors List
Latterell Venture Partners
Latterell Venture Partners investment in Series C - Calistoga Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series C - Calistoga Pharmaceuticals
Alta Partners
Alta Partners investment in Series C - Calistoga Pharmaceuticals
Quogue Capital
Quogue Capital investment in Series C - Calistoga Pharmaceuticals
Three Arch Partners
Three Arch Partners investment in Series C - Calistoga Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Calistoga Pharmaceuticals
Alta Partners
Alta Partners investment in Series B - Calistoga Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Calistoga Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series B - Calistoga Pharmaceuticals
Three Arch Partners
Three Arch Partners investment in Series B - Calistoga Pharmaceuticals
Official Site Inspections
http://www.calistogapharma.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney